Tag: Chembio Diagnostics
July 18, 2019
Chembio Diagnostics and Takeda Pharmaceutical to Collaborate
Chembio Diagnostics (NASDAQ:CEMI) has announced it has entered into an agreement with Shire Human Genetic Therapies, a subsidiary of Takeda... April 2, 2019
Chembio Diagnostics Announces Agreement with Perseus Science to Advance Point-of-Care Concussion Test
Chembio Diagnostics (NASDAQ:CEMI) has announced it has entered into an agreement with Perseus Science Group to advance developing a diagnostic... April 25, 2018
Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases
Chembio Diagnostics (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into a collaboration... March 9, 2018
Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results
Chembio Diagnostics (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today reported financial results for the fourth quarter... February 9, 2018
Chembio Diagnostics Announces Proposed Public Offering of Common Stock
Chembio Diagnostics (NASDAQ:CEMI) a leader in point-of-care diagnostic tests for infectious diseases, announced today that it has commenced an underwritten... May 3, 2017